Pratik Shah - 04 Jun 2024 Form 4/A Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director, 10%+ Owner
Signature
Kathleen Scott, Attorney-in-Fact, for The Pratik Shah Living Trust dated June 15, 2011
Issuer symbol
SPRY
Transactions as of
04 Jun 2024
Net transactions value
$0
Form type
4/A
Filing time
07 Jun 2024, 21:09:10 UTC
Date Of Original Report
06 Jun 2024
Previous filing
05 Sep 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Other -2,665,800 -26% 7,490,404 04 Jun 2024 By The Pratik Shah Living Trust dated June 15, 2011 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1, of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1, of which an adult son of Dr. Shah is a beneficiary. Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust.
F2 Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011.

Remarks:

The Reporting Persons are filing this amendment solely to replace Footnote 1 in the Form 4 filed on June 6, 2024.